Metabolic stability of proteasome inhibitors and midazolam using pooled
human liver microsomes. The metabolism of MG-132 (A), epoxomicin (B), and
bortezomib (C) by HLM were monitored by a substrate depletion method.
Aliquots were taken from the incubation mixtures at 0, 5, 10, 15, 20, and 30
min, and the quenched samples were analyzed by LC-MS/MS. Ketoconazole (1
μM) was used as a competitive inhibitor of CYP3A4.